# RANOLAZINE
> **ANDA211865** · Abbreviated New Drug Application (Generic) · Sponsor: SUNSHINE · Approved 2020-03-23
## Drug
- **FDA Application Number:** ANDA211865
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANOLAZINE
- **Generic name:** Ranolazine
- **Active ingredients:** RANOLAZINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SUNSHINE
- **First approval:** 2020-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211865)
---
*MORVS · CC0 1.0*